- Everyday Alpha
- Posts
- The Power Stock That Still Looks Buyable, Even at a Premium
The Power Stock That Still Looks Buyable, Even at a Premium
AI is quietly turning electricity into the next strategic commodity.
Data centers, electrification, and grid constraints are colliding at the same time, and the market is starting to pay up for companies that already own reliable generation and can lock in long contracts.

Earn a master's in AI for under $2,500
AI skills are no longer optional—they’re essential for staying competitive in today’s workforce. Now you can earn a fully accredited Master of Science in Artificial Intelligence from the Udacity Institute of AI and Technology, awarded by Woolf, an accredited higher education institution.
This 100% online, flexible program is designed for working professionals and can be completed for under $5,000. You’ll build deep, practical expertise in modern AI, machine learning, generative models, and production deployment through real-world projects that demonstrate job-ready skills.
Learn on your schedule, apply what you build immediately, and graduate with a credential that signals serious AI capability. This is one of the most accessible ways to earn a graduate-level AI degree and accelerate your career.

Never Miss a Stock Alert Again!
We now send our daily picks via SMS too — so you’ll get the same high-conviction ideas, even if you miss the email.

Coupang | CPNG

Price: $24.13
Coupang is dealing with the kind of headline risk that can linger, a major data breach and a very large compensation plan.
The company has pledged roughly $1.17 billion in vouchers for affected users, including former customers, with eligibility checks beginning mid-January.
That is a big number, but the logic is clear. In e-commerce, trust is not a brand attribute, it is the business model.
If the compensation helps stabilize retention and prevents a slow bleed of customer engagement, it could be a painful but rational one-time reset.
The risk is the opposite outcome, prolonged regulatory scrutiny, higher customer acquisition costs, and a perception that the platform is less safe.
In that case, the stock can stay trapped under an overhang even if operational execution remains strong.
Why it matters for you: CPNG is a watchlist situation until the market sees clean user metrics again.
If retention holds and the story becomes a closed chapter, the stock could re-rate. If it becomes a rolling investigation cycle, patience will be tested.

MGM Resorts | MGM

Price: $36.74
MGM is a confidence stock. When consumers feel good, travel and entertainment spending rises, casino floors stay busy, and premium experiences sell.
When confidence slips, discretionary wallets tighten fast. That is why MGM tends to react to macro mood swings more than many people expect.
The near-term story is straightforward.
Big event weekends can meaningfully boost Vegas demand, and BetMGM gives the company a digital lever that can surprise during peak sports calendars.
The longer-term story includes the Osaka integrated resort project, which signals MGM is still playing offense internationally, not just harvesting Vegas cash flows.
The risk is also straightforward. If the economy cools hard, leisure spend is one of the first places households cut back.
MGM can still be a good business in that environment, but the stock typically loses its shine.
Why it matters for you: MGM can work as a cyclical upside play if the economy stays stable and travel demand holds.
If the consumer weakens, treat this as something to size carefully, not a set-and-forget.

Don’t Miss Out (Sponsored)
A dramatic transformation in the financial system is creating unprecedented wealth—but most Americans aren’t ready.
Traditional investing strategies may leave you behind.
Analysts who predicted past market crashes say a unique opportunity is forming right now.
One-person companies and innovative approaches are generating massive gains faster than ever before.
Access the Free Briefing

Moderna | MRNA

Price: $30.41
Moderna is still climbing out of the post-pandemic valuation hangover.
The core challenge is that COVID vaccine demand is structurally lower, and investors want proof that Moderna can build a durable multi-product franchise that does not rely on one blockbuster.
The bull case is the platform.
Moderna proved mRNA can scale commercially, and it is using that foundation to expand a broader respiratory franchise while pushing into oncology and other pipeline areas.
Cost discipline also matters here because it extends runway and increases the value of any clinical wins that land in the next couple of years.
The bear case is the nature of biotech. Programs fail, timelines slip, and sentiment can swing wildly around trial readouts.
That makes the stock prone to sharp moves even when the long-term thesis stays intact.
Why it matters for you: MRNA is a high-variance recovery story. If you want exposure, think basket sizing and catalyst awareness.
The upside comes from pipeline progress, but the path will not be smooth.

Autodesk | ADSK

Price: $299.54
Autodesk is the kind of software name investors tend to trust when the macro gets messy.
Its tools sit inside real workflows, architecture, engineering, construction, and manufacturing.
That matters because it creates sticky demand, high switching costs, and durable pricing power when customers depend on the platform to keep projects moving.
The company also has a clear margin story. If it continues to execute, it can grow revenue while improving operating leverage over time.
That is the type of profile that often outperforms in a cooling economy, especially if rates stay supportive and investors rotate toward quality.
The main risk is cyclical exposure. If construction activity and capital spending slow meaningfully, seat expansion and usage-based growth can soften.
Autodesk is resilient, but it is still connected to the pace of building and industrial project work.
Why it matters for you: ADSK is a steady compounder candidate.
If growth remains intact and margins keep improving, the stock can work as a quality anchor in a choppier 2026 tape.

Constellation Energy | CEG

Price: $357.12
CEG is one of the cleanest ways to play a simple, underappreciated shift: power demand is rising faster than supply additions, and reliability is becoming more valuable.
Nuclear sits at the center of that story because it provides baseload generation with low carbon intensity, exactly what large power buyers want when they are signing multi-year contracts to support data centers and industrial load growth.
Yes, the stock looks expensive. The key point is that sometimes a premium valuation is the market acknowledging scarcity.
If the U.S. is entering a period where power becomes constrained, the owners of large, reliable generation fleets can hold pricing power longer than typical utility comparisons suggest.
What would change the story is a real demand disappointment.
If hyperscalers pull back capex meaningfully, or if policy turns sharply against nuclear economics, the multiple can compress.
But in a world where electricity becomes the bottleneck behind AI growth, the higher valuation starts to look like the cost of admission.
Why it matters for you: If you believe power demand stays elevated and grid constraints persist, CEG still looks like a buy, even here.
The premium is real, but the structural setup may be bigger.

Trivia: Which U.S. coin has Roosevelt on it? |

📊 Stat of the Day: 1.8%
The share of U.S. workers quitting their jobs has fallen to 1.8%, the lowest since May 2020. That is a classic cooling-labor-market signal.
Fewer people quitting usually means workers feel less confident about jumping to something better, which can ease wage pressure and keep inflation cooler.
Best Regards,
—Noah Zelvis
Everyday Alpha



